Teva Valsartan/HCTZ Product Recall (2018-08-17)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 35210937R, 35210938R, 35210393R, 35210940R | D. Teva-Valsartan/HCTZ 160mg/25mg Tablet | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02357011 | Valsartan 160mg |
| 35211335A, 35211844R | B. Teva-Valsartan/HCTZ 160mg/12.5mg Tablet | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02357003 | Valsartan 160mg |
| 35211546R | C. Teva-Valsartan/HCTZ 320mg/12.5mg Tablet | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02357003 | Valsartan 320mg |
| 35211136A | A. Teva-Valsartan/HCTZ 80mg/12.5mg Tablet | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02356996 | Valsartan 80mg |
Recalled Products
-
Teva-Valsartan/HCTZ 80mg/12.5mg Tablet
-
Teva-Valsartan/HCTZ 160mg/12.5mg Tablet
-
Teva-Valsartan/HCTZ 320mg/12.5mg Tablet
-
Teva-Valsartan/HCTZ 160mg/25mg Tablet
Affected lots may be manufactured with an API containing a contaminant.
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67514r-eng.php